Novogene Tianjin to offer end-to-end sequencing through interpretation and reporting by integrating LifeMap’s leading TGex Clinical NGS tertiary analysis platform with their sequencing and bioinformatics services in China Partnership to expand LifeMap’s access to the Chinese Market ALAMEDA, Calif. – LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE)  announced today that Tianjin

To read the full story...

Already a subscriber? Login now

< | >